Basal sFAS/sFASL ratio and FAS polymorphisms, as a prognostic marker, in advanced colorectal carcinoma patients (ACRC), treated with oxaliplatin-based chemotherapy.

被引：0
|
作者：
Gascon, P
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：278S / 278S
页数：1
相关论文
共 50 条
  • [31] The dynamic changes of circulating myeloid-derived suppressor cells (MDSCs) subsets in patients with colorectal cancer undergoing oxaliplatin-based chemotherapy.
    Fauza, Dilafitria
    Manuel, Ralph G.
    Sudoyo, Aru Wisaksono
    Steven, Ricci
    Gultom, Fajar Lamhot
    Basir, Ibrahim
    Kurniawan, Dicky
    Budiyati, Akterono Dwi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 62 - 62
  • [32] Preliminary results from a study of sevacizumab in Chinese patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapy.
    Xu, Nong
    Cao, Junning
    Zhang, Yanqiao
    Ding, Yanhua
    Mao, Chenyu
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Pharmacodynamic study of soluble FAS (sFAS) and FASL (sFASL), in patients (pts) with advanced colorectal cancer (ACRC) after irinotecan and cetuximab treatment in third-line therapy: Results of HCB-05-01 trial
    Garcia-Albeniz, X.
    Pericay, C.
    Alonso, V.
    Escudero, P.
    Fernandez-Martos, C.
    Auge, J.
    Gallego, R.
    Tosca, M.
    Gascon, P.
    Maurel, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases
    Ribero, Dario
    Wang, Huamin
    Donadon, Matteo
    Zorzi, Daria
    Thomas, Melanie B.
    Eng, Cathy
    Chang, David Z.
    Curley, Steven A.
    Abdalla, Eddie K.
    Ellis, Lee M.
    Vauthey, Jean-Nicolas
    CANCER, 2007, 110 (12) : 2761 - 2767
  • [35] PROGNOSTIC AND PREDICTIVE ROLES OF DNA MISMATCH REPAIR STATUS IN COLON CANCER PATIENTS TREATED WITH OXALIPLATIN-BASED CHEMOTHERAPY: A RETROSPECTIVE STUDY
    Qin, Q.
    Zhou, A. -P.
    Yang, L.
    Xu, C.
    Sun, Y. -K.
    Zhang, W.
    Wang, J. -W.
    Zhong, D. -S.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 71 (04): : 573 - 580
  • [36] Genomic profiling as predictor of toxicity in patients with advanced colorectal cancer treated with platinum-based chemotherapy.
    Park, DJ
    Yun, J
    Yang, DY
    Iqbal, S
    Press, O
    Groshen, S
    Gordon, M
    Zhang, W
    Lenz, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 276S - 276S
  • [37] BEVACIZUMAB IMPROVES PATHOLOGIC RESPONSE IN PATIENTS TREATED WITH OXALIPLATIN-BASED CHEMOTHERAPY FOR COLORECTAL LIVER METASTASES: REPORT FROM A RETROSPECTIVE STUDY
    Vera, R.
    Gomez, M. L.
    Arrazubi, V.
    Zazpe, C.
    Teijeira, L.
    Lainez, N.
    Tarifa, A.
    Hernandez, B.
    Martinez, M.
    Illarramendi, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 216 - 217
  • [38] MGMT −535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy
    Jee Hyun Park
    Nung Soo Kim
    Jae Yong Park
    Yee Soo Chae
    Jong Gwang Kim
    Sang Kyun Sohn
    Joon Ho Moon
    Byung Woog Kang
    Hun Mo Ryoo
    Sung Hwa Bae
    Gyu Seog Choi
    Soo-Han Jun
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1135 - 1142
  • [39] Analysis of oxaliplatin-based chemotherapy induced liver injury in patients with advanced colorectal cancer with special references to von Willebrand factor
    Nishigori, N.
    Matsumoto, M.
    Koyama, F.
    Hayakawa, M.
    Hatakeyama, K.
    Fujimura, Y.
    Nakajima, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 751 - 752
  • [40] Predictive value of VEGF gene polymorphisms in metastatic colorectal cancer patients treated with a bevacizumab-based chemotherapy.
    Ulivi, Paola
    Marisi, Giorgia
    Scarpi, Emanuela
    Passardi, Alessandro
    Ragazzini, Angela
    Frassineti, Giovanni Luca
    Zoli, Wainer
    Valgiusti, Martina
    Nanni, Oriana
    Calistri, Daniele
    Casacci, Fabio
    Amadori, Dino
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345